These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 8167198)

  • 1. Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia.
    Buckley P; O'Callaghan E; Mulvany F; Larkin C; Stack JP; Redmond O; Ennis JT; Thompson P; Waddington JL
    Psychiatry Res; 1995 Aug; 61(2):95-102. PubMed ID: 7480392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI in tardive dyskinesia: shortened left caudate T2.
    Bartzokis G; Garber HJ; Marder SR; Olendorf WH
    Biol Psychiatry; 1990 Dec; 28(12):1027-36. PubMed ID: 1981152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia.
    Glazer WM; Hafez H
    Schizophr Res; 1990; 3(5-6):315-20. PubMed ID: 1980827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study.
    Elkashef AM; Buchanan RW; Gellad F; Munson RC; Breier A
    Am J Psychiatry; 1994 May; 151(5):752-5. PubMed ID: 7909412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal ganglia iron in tardive dyskinesia: an MRI study.
    Elkashef AM; Egan MF; Frank JA; Hyde TM; Lewis BK; Wyatt RJ
    Biol Psychiatry; 1994 Jan; 35(1):16-21. PubMed ID: 8167198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology of tardive dyskinesia: an overview.
    Jeste DV; Wyatt RJ
    Am J Psychiatry; 1981 Mar; 138(3):297-309. PubMed ID: 6110344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence.
    Gold R; Lenox RH
    J Clin Psychiatry; 1995 Oct; 56(10):476-83. PubMed ID: 7559375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
    Correll CU; Leucht S; Kane JM
    Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.